How would you approach a T1N1 NSCLC with a small peripheral primary tumor and single hilar node in a patient not fit for concurrent chemo or surgery?

Topics: Radiation Oncology • Thoracic Malignancies • Medical Oncology

Would you offer SBRT to both sites, SBRT to the primary and standard fractionation to the node due to proximity to the main bronchus/proximal lobar bronchus? Would your recommendation change for a patient previously treated with SBRT for a peripheral tumor at least 2 years prior?

What about SCLC?

Answer from: Radiation Oncologist at Community Practice

If the patient were not a candidate for surgery or chemotherapy, then I would favor hypofractionated radiotherapy to 60 Gy in 15 fractions to both the primary and the hilar lymph node based on UTSW phase I data. If the patient may be a candidate for immunotherapy, then I would strongly consider enro...

Comments

Radiation Oncologist at Northeast Alabama Regional Medical Center
Assuming this is a T1N1 small cell lung cancer, wi...

Related Questions